| June 30,2002 |
Angiotensin-converting enzyme 2 is an essential regulator of heart function |
|
Ace2 maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of
hypertension. In all hypertensive rat strains, ACE2 mRNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased
angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.
|
| June 29,2002 |
On the TRAIL to apoptosis |
|
Apoptosis in mammalian cells can be initiated through two major interrelated pathways, one involving engagement of the TNF family of death receptors, the other involving the release of cytochrome c from mitochondria. Unlike other members of the TNF ligand family,
TNF-related apoptosis-inducing ligand (TRAIL) preferentially induces apoptosis in tumor cell lines, but not in normal cells, suggesting that TRAIL could potentially represent a powerful cancer therapeutic.
|
| June 28,2002 |
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress
experimental autoimmune encephalomyelitis |
|
Poly (Y, F, A, K) (YFAK)
inhibited binding of the biotinylated MBP 86-100 epitope to HLA-DR2 molecules more efficiently than did either unlabeled MBP 85-99 or any other copolymer. Most importantly, these novel copolymers suppressed experimental autoimmune encephalomyelitis.
|
| June 27,2002 |
Targeted adenoviral gene transfer to the kidney |
|
In vivo administration of the chimeric adenoviral vector into the renal artery of the rat resulted in significantly enhanced β-galactosidase expression in the vascular endothelium of the kidney compared with an adenoviral vector containing the native adenoviral fiber protein (AdZ).
|
| June 26,2002 |
Calcium signaling: A tale for all seasons |
|
The rapid advancement of the Calcuim signal field has now swollen the
literature to a size where it would be impossible to cover all of
it in a few pages. Because a number of comprehensive reviews
are available, this contribution will focus only on the most significant recent advances.
|
| June 25,2002 |
A vaccine against atherosclerosis |
|
The development of a vaccine to prevent
the build-up of atherosclerotic plaque has come a step closer. Researchers at
the Cedars-Sinai Medical Center (Los Angeles, CA, USA) and Lund University
(Malmo, Sweden) have tested a peptidebased vaccine that reduces arterial
plaque formation in mice by up to 70%.
|
| June 24,2002 |
Nonremodeling Properties
of Matrix Metalloproteinases |
|
Recently, a number of contributions
have shown that in addition to chronic remodeling reactions, MMPs(Matrix Metalloproteinases) are involved in acute biological reactions associated with discrete cell signaling such as regulation of vascular reactivity,leukocyte activation,and platelet function.
|
| June 23,2002 |
Young Adult Bone Marrow–Derived
Endothelial Precursor Cells Restore Aging-Impaired Cardiac
Angiogenic Function |
|
Delivery of young bone marrow–derived stem cells offers a novel approach for restoring the impaired senescent
cardiac angiogenic function that may underlie the increased morbidity and mortality associated with ischemic heart disease in older individuals.
|
| June 22,2002 |
New Treatments for
COPD |
|
Chronic Obstructive Pulmonary Disease (COPD),is one of the most common diseases in the world, and there is a global increase in
prevalence.A better understanding of the cellular and molecular mechanisms that are
involved in the underlying inflammatory and destructive processes has revealed several new
targets for which drugs are now in development, and the prospects for finding new treatments
are good.
|
| June 21,2002 |
The impact of pharmacogenetics
and pharmacogenomics on drug discovery |
|
The implementation of molecular genetics and biology will provide us with better ways to treat illnesses, and has already begun to do
so in an incremental and evolutionary fashion.Advances are most likely to be made in the
area of pharmacodynamics, as we learn to differentiate broader conventional clinical
diagnoses into separate molecular subtypes.
|
| June 20,2002 |
Gene Therapy to Protect
Haematopoietic Cell From Cytotoxic Cancer Drugs |
|
Several gene-therapy vectors
have been developed with the aim of expressing drug-resistance genes specifically in bonemarrow stem cells, so protecting them from chemotherapeutics. The feasibility of this approach has been established in animal model systems, and recent advances in the design of genetherapy vectors offer promise for future clinical applications.
|
| June 19,2002 |
Cardiomyocyte Cell Cycle
Regulation |
|
Although rapid progress is being made in many areas of molecular cardiology, issues pertaining to the origins
of heart-forming cells, the mechanisms responsible for cardiogenic induction, and the pathways that regulate cardiomyocyte proliferation during embryonic and adult life remain unanswered.
|
| June 18,2002 |
Functional Significance
of Prorenin Internalization in the Rat Heart |
|
One mechanism of internalization recently described involves the mannose-6-phosphate receptor and requires glycosylation of renin. Based on previous observations, we considered the existence of another pathway of uptake, not requiring glycosylation and predominantly involving prorenin.
|
| June 17,2002 |
G Protein Pathways
|
|
The heterotrimeric guanine nucleotide–binding proteins (G proteins) are signal transducers that communicate signals from many hormones, neurotransmitters, chemokines, and autocrine and paracrine factors. The extracellular signals are received by members of a large superfamily of receptors with
seven membrane-spanning regions that activate the G proteins, which route
the signals to several distinct intracellular signaling pathways.
|
| June 16,2002 |
Encoding Microcarriers:
Present and Future Technologies |
|
In answer to the ever-increasing need to carry out many assays simultaneously in drug screening and drug discovery, several microcarrier-based multiplex technologies have arisen in the past fewyears.In this article, the methods that have been developed for the encoding of microcarriers are reviewed and discussed.
|
| June 15,2002 |
Angiogenesis Modulation
in Cancer Research:Novel Clinic Approaches |
|
The modulation of tumour angiogenesis using novel agents has become a highly active area of investigation in cancer research, from the bench to the clinic.Here, we discuss methods for monitoring the biological activity of angiogenic modulators, and innovative approaches to trial design that might facilitate the integration of these agents into anticancer therapy.
|
| June 14,2002 |
PI 3-Kinases and PTEN: How
Opposites Chemoattract |
|
Phosphatidylinositol lipids, such as PI(4,5)P2 and PI(3,4,5)P3, are key mediators in diverse intracellular
signaling pathways. Two recent reports examine how the metabolism of these lipids by phosphatidylinositol 3-kinases and the PTEN 3-phosphoinositide phosphase may coordinate G protein coupled signaling pathways during eukaryotic chemotaxis.
|
| June 13,2002 |
T Lymphocytes in Atherosclerosis
|
|
The presence of activated T lymphocytes in all stages of human atherosclerotic lesion development implies their involvement in this vascular disease process. However, the specific role T lymphocytes play in atherogenesis
remains unclear.
|
| June 12,2002 |
New vaccine development
|
|
This review describes recent
developments in the basic science underpinning the development of new vaccines and summarises the potential of the vaccines to treat and prevent a wide range of infectious and non-infectious diseases.
|
| June 11,2002 |
Specialized DNA Polymerases, Cellular Survival,and the Genesis of Mutations
|
|
Cell death caused by arrested replication of damaged or structurally altered DNA can be avoided in prokaryotic and eukaryotic cells by multiple DNA polymerases that are specialized to bypass DNA damage.
The low fidelity of some of these specialized polymerases when copying undamaged DNA may be
physiologically functional, including generating immunoglobulin diversity.
|
| June 10,2002 |
At the Center of Eukaryotic Life
|
|
The ribosomal RNA genes encode the enzymatic scafold of the ribosome and thereby perform perhaps the most basic of all housekeeping functions. However,recent data suggests that they might also control important aspects of cell behavior.
|
| June 09,2002 |
Comparative assessment
of large-scale data sets of protein–protein interactions
|
|
Recently, large-scale approaches have predicted many new protein interactions in yeast. To measure their accuracy and potential as well as to identify biases, strengths and weaknesses,
we compare the methods with each other and with a reference set of previously reported protein interactions.
|
| June 08,2002 |
Combinatorial Synthesis
of Genetic Networks
|
|
Creation and analysis of synthetic networks,
composed of well-characterized genetic elements, provide a framework
for theoretical modeling. Here, with the use of a combinatorial
method, a library of networks with varying connectivity was
generated in E. coli.
|
| June 07,2002 |
T-cell antigen
receptor signal transduction |
|
T-cell activation by foreign antigen induces antigen specific T-cell clonal expansion and differentiation and this response
is regulated by signal transduction pathways initiated by antigen receptors and costimulatory molecules.This review will cover recent progress from biochemistry, genetics and cell biology
towards understanding the signal transduction pathways that control T-cell activation.
|
| June 06,2002 |
Coronary Anomalies:
Incidence, Pathophysiology, and Clinical Relevance |
|
Although the medical community and general public are increasingly aware that coronary anomalies can be fatal (typically in young, previously
“healthy” athletes), the reasons for the sudden fatal event and the frequency with which it occurs are generally unclear. To promote a less casual approach to this subject, we
review some basic, substantive, and methodological questions about coronary anomalies.
|
| June 05,2002 |
Lipases and
HDL metabolism |
|
HDL metabolism is recognized as a potential target for therapeutic intervention of atherosclerotic vascular diseases.
Here,we focus on new developments and insights into the role of secreted lipases on
HDL metabolism and their relationship to atherosclerosis.
|
| June 04,2002 |
Centrosomes and cancer: lessons from
a TACC |
|
The recent discovery that many cancer cells have centrosomal abnormalities
suggests a link between centrosomes and cancer. Members of the
transforming acidic coiled-coil (TACC) family of proteins have been implicated in cancer and are concentrated at centrosomes, where they regulate microtubule stability.
|
| June 03,2002 |
Molecules in focus:
Clusterin |
|
Clusterin is an enigmatic glycoprotein with a nearly ubiquitous tissue distribution and an apparent involvement in biological
processes ranging from mammary gland involution to neurodegeneration in Alzheimer’s disease.
|
| June 02,2002 |
Translational Control of the Embryonic Cell Cycle |
|
The synthesis and destruction of cyclin B drives mitosis in eukaryotic cells. Cell cycle progression is also regulated at the level of cyclin B translation.Observations suggest that regulated cyclin B1 mRNA translation is essential for the embryonic cell cycle.
|
| June 01,2002 |
Views of Transcription Initiation |
|
Initiation of transcription is the first step in gene expression and a major point of regulation. Recent structure studies reveal the nature of the initiating complex
and suggest new ways of accomplishing the processes required for initiation.
|